Goodwin Investment Advisory’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$648 59
2023
Q4
$648 Sell
12
-944
-99% -$46.1K ﹤0.01% 69
2023
Q3
$46.4K Hold
956
0.03% 64
2023
Q2
$54K Sell
956
-220
-19% -$12.1K 0.03% 62
2023
Q1
$63.5K Sell
1,176
-13
-1% -$692 0.04% 62
2022
Q4
$62.5K Sell
1,189
-1,322
-53% -$67.1K 0.04% 76
2022
Q3
$118K Sell
2,511
-67,485
-96% -$3.5M 0.09% 58
2022
Q2
$3.53M Buy
69,996
+4,865
+7% +$265K 2.72% 8
2022
Q1
$3.93M Buy
65,131
+8,146
+14% +$486K 2.7% 8
2021
Q4
$3.73M Buy
56,985
+41,307
+263% +$2.64M 2.79% 8
2021
Q3
$982K Buy
15,678
+3,978
+34% +$254K 0.95% 14
2021
Q2
$702K Sell
11,700
-46,092
-80% -$2.67M 0.76% 13
2021
Q1
$3.19M Sell
57,792
-22,272
-28% -$1.24M 3.75% 6
2020
Q4
$4.38M Buy
+80,064
New +$4.19M 5.36% 4

Other funds holding IHI

Goodwin Investment Advisory's IHI Position: Q1 2024 in Review

Goodwin Investment Advisory sold out of iShares US Medical Devices ETF (IHI) in Q1 2024, closing a stake of 12 shares — an estimated $648 sold.

Goodwin Investment Advisory first reported a position in IHI in Q4 2020 and held it in 13 quarters. The position peaked at $4.38M in Q4 2020. 581 funds tracked by Wall St. Rank hold IHI as of Q1 2024.

  • Goodwin Investment Advisory reported no remaining iShares US Medical Devices ETF position as of Q1 2024 after selling out during the quarter.
  • Goodwin Investment Advisory sold 12 iShares US Medical Devices ETF shares in Q1 2024, an estimated $648.
  • Goodwin Investment Advisory first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 13 quarters.
  • Goodwin Investment Advisory's iShares US Medical Devices ETF position peaked at $4.38M in Q4 2020.
  • 581 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2024.

Based on Goodwin Investment Advisory's 13F filing for Q1 2024, filed 6 May 2024.